MedTrace Logo

Assessment System of Sarcopenia in Lung Cancer Patients

NCT06327594 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2024-03-25

No results posted yet for this study

Summary

1. To explore the diagnostic value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI for sarcopenia in patients with lung cancer.
2. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the prognosis and the effect of nutritional support in patients with lung cancer during perioperative period.
3. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the long-term prognosis of patients with lung cancer.

Conditions

Interventions

DIAGNOSTIC_TEST

ultrasound scan

The patients with lung cancer who are scheduled to undergo radical resection of lung cancer are examined by ultrasound at multiple sites of the whole body, including muscle and fat.

DIAGNOSTIC_TEST

CT/MRI scan

The patients with lung cancer who are scheduled to undergo radical resection of lung cancer are examined by abdominal CT/MRI.

Sponsors & Collaborators

  • West China Hospital

    lead OTHER

Principal Investigators

  • Xinyi Tang · Department of Medical Ultrasound, West China Hospital, Sichuan University

Eligibility

Min Age
40 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2027-11-30
Completion
2028-11-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06327594 on ClinicalTrials.gov